Stanford University's Stephen Quake tells the New York Times that he encouraged CRISPR researcher He Jiankui to seek the proper ethical approvals.
The researchers reported that most of these changes, though not all, reverted to normal upon the astronaut's return to Earth.
The recovery tool applies click chemistry-based DNA attachments on agarose beads to allow repetitive primer extension for specific gene targets.
With ancient mitochondrial sequences from all seven Canary Islands, researchers identified at least two early migrations involving shifting populations from North Africa.
Through this analysis, the researchers uncovered borders between active and repressed chromatin that varied by cell type.
The researchers are developing a web-based tool to help physicians predict their patients' relapse risk and are planning clinical trials to study outcomes.
Singapore-based Lucence Diagnostics will team with Stanford to analyze sequencing and imaging of liver cancer patients to predict therapeutic effectiveness.
Four awardees will use Intermountain's NGS One Genomic Services for projects that focus on precision medicine, clinical, and translational research.
In PNAS this week: methanogen ancestry, within-host human cytomegalovirus genetic diversity, and more.
In Science this week: a pair of papers finds cytosine base editors can generate off-target mutations, and more.
A man has confessed to the rape and murder of developmental biologist Suzanne Eaton, according to the New York Times.
The Irish Times reports that US lawmakers and law enforcement agencies are concerned about ties between the US and Chinese genomics firms.
Parents of children with spinal muscular atrophy tell the Washington Post they are pushing to get insurance coverage of Novartis's Zolgensma.
In PNAS this week: gene mutations in individuals with syndromic craniosynostosis, putative colorectal cancer drivers, and more.